{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:04:36Z","timestamp":1773421476347,"version":"3.50.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>This study aimed to determine the decrease in opioid and benzodiazepine doses associated with the development of withdrawal in children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING:<\/jats:title>\n                    <jats:p>Electronic health record data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>INTERVENTION:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS:<\/jats:title>\n                    <jats:p>Four hundred and seven children who received invasive mechanical ventilation (IMV) between January 1, 2012 and January 1, 2022 with Withdrawal Assessment Tool-1 (WAT-1) scores during their IV opioid wean were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n                    <jats:p>The primary outcome was development of withdrawal, defined as a WAT-1 score greater than or equal to 3, during the IV opioid weaning phase. Descriptive data included age, weight, insurance, race, ethnicity, language, comorbidities, length of stay, and IMV duration. WAT-1 scores were recorded, and the cumulative IV and enteral opioids, benzodiazepines, and A2As were calculated. Recent changes in IV opioid and benzodiazepine doses were assessed in the 16 hours before each WAT-1 score divided into 4-hour periods. Doses were compared across 4-hour periods, and a multivariable mixed-effects model was used to assess their association with withdrawal. The presence of greater than or equal to 2 pediatric complex chronic condition classification system version 2 (CCC-V2) diagnosis categories (odds ratio [OR] 3.35; 95% CI, 2.61\u20135.15) was associated with withdrawal. Heart disease, prematurity, and IV opioid class switching did not qualify for model inclusion. Cumulative IV opioid dose and a decrease in opioid exposure between 16\u201312 and 4\u20130 hours before the WAT-1 score were associated with withdrawal (OR 1.02; 95% CI, 1.01\u20131.03; OR 1.92; 95% CI, 1.38\u20133.16). Morphine was associated with increased odds of withdrawal compared with fentanyl and hydromorphone (OR 1.48; 95% CI, 1.37\u20131.81). The model did not establish an association between cumulative IV benzodiazepine exposure or IV benzodiazepine dose decrease and withdrawal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Patients with a higher cumulative IV opioid dose, an IV opioid wean in the preceding 8\u201312 hours, and greater than or equal to 2 CCC-V2 categories had the highest odds of withdrawal in this single-center study. Morphine was associated with increased odds of withdrawal as well.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cce.0000000000001391","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:00:09Z","timestamp":1773417609000},"page":"e1391","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Association of Iatrogenic Withdrawal With Opioid and Benzodiazepine Weaning in Children With Bronchiolitis: A Single-Center, Retrospective Cohort Study, 2012\u20132022"],"prefix":"10.1097","volume":"8","author":[{"given":"Alice","family":"Shanklin","sequence":"first","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Children\u2019s National Hospital, Washington, DC."},{"name":"Division of Pediatric Critical Care Medicine, Cohen Children\u2019s Medical Center, Queens, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo A. Trujillo","family":"Rivera","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Children\u2019s National Hospital, Washington, DC."},{"name":"Research Division of Biostatistics and Study Methodology, Department of Pediatrics, George Washington University, Washington DC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray M.","family":"Pollack","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Children\u2019s National Hospital, Washington, DC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita K.","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Children\u2019s National Hospital, Washington, DC."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"R1-20260313","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200003303421306","article-title":"Sedation and analgesia for procedures in children.","volume":"342","author":"Krauss","year":"2000","journal-title":"N Engl J Med"},{"key":"R2-20260313","doi-asserted-by":"crossref","first-page":"509","DOI":"10.21037\/atm.2019.09.16","article-title":"Sedation strategies in children with pediatric acute respiratory distress syndrome (PARDS).","volume":"7","author":"Rosenberg","year":"2019","journal-title":"Ann Transl Med"},{"key":"R3-20260313","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PCC.0b013e318253c80e","article-title":"Opioid analgesia in mechanically ventilated children: Results from the multicenter measuring opioid tolerance induced by fentanyl study.","volume":"14","author":"Anand","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R5-20260313","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5409\/wjcp.v6.i2.110","article-title":"Conversion from prolonged intravenous fentanyl infusion to enteral methadone in critically ill children.","volume":"6","author":"Srinivasan","year":"2017","journal-title":"World J Clin Pediatr"},{"key":"R6-20260313","first-page":"42","article-title":"Exposure-based methadone and lorazepam weaning protocol reduces wean length in children.","volume":"26","author":"Wilson","year":"2021","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R7-20260313","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/PCC.0b013e31818c8328","article-title":"The withdrawal assessment tool-1 (WAT-1): An assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients.","volume":"9","author":"Franck","year":"2008","journal-title":"Pediatr Crit Care Med"},{"key":"R8-20260313","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1097\/PCC.0000000000003645","article-title":"Development and preliminary testing of the withdrawal assessment tool-alpha 2 agonist: An assessment instrument for monitoring iatrogenic withdrawal symptoms in children receiving an alpha-2 agonist.","volume":"26","author":"Solodiuk","year":"2025","journal-title":"Pediatr Crit Care Med"},{"key":"R9-20260313","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00003246-199405000-00009","article-title":"Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion.","volume":"22","author":"Katz","year":"1994","journal-title":"Crit Care Med"},{"key":"R10-20260313","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/PCC.0000000000000080","article-title":"Methadone: Who tapers, when, where, and how?","volume":"15","author":"Tobias","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R11-20260313","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/PCC.0000000000000048","article-title":"Evaluation of a pharmacist-managed methadone taper*.","volume":"15","author":"Steineck","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R12-20260313","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/PCC.0b013e3181fe38f5","article-title":"A trial of methadone tapering schedules in pediatric intensive care unit patients exposed to prolonged sedative infusions.","volume":"12","author":"Bowens","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"R13-20260313","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/0897190019875613","article-title":"Iatrogenic opiate withdrawal in pediatric patients: Implementation of a standardized methadone weaning protocol and withdrawal assessment tool.","volume":"34","author":"Walters","year":"2021","journal-title":"J Pharm Pract"},{"key":"R14-20260313","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/PHAR.1001","article-title":"Selection of the initial methadone regimen for the management of iatrogenic opioid abstinence syndrome in critically ill children.","volume":"32","author":"Johnson","year":"2012","journal-title":"Pharmacotherapy"},{"key":"R15-20260313","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.sapharm.2011.12.002","article-title":"A pilot study assessing the frequency and complexity of methadone tapers for opioid abstinence syndrome in children discharged to home.","volume":"8","author":"Johnson","year":"2012","journal-title":"Res Social Adm Pharm"},{"key":"R16-20260313","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/pan.13056","article-title":"The use of methadone to facilitate opioid weaning in pediatric critical care patients: A systematic review of the literature and meta\u2010analysis.","volume":"27","author":"Dervan","year":"2017","journal-title":"Paediatr Anaesth"},{"key":"R17-20260313","doi-asserted-by":"crossref","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies conducted using observational routinely-collected health data (RECORD) statement.","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"R18-20260313","doi-asserted-by":"crossref","first-page":"e1234","DOI":"10.1097\/CCM.0000000000005210","article-title":"Noninvasive ventilation and outcomes in bronchiolitis*.","volume":"49","author":"Shanahan","year":"2021","journal-title":"Crit Care Med"},{"key":"R19-20260313","doi-asserted-by":"crossref","first-page":"e051345","DOI":"10.1542\/peds.2021-051345","article-title":"Patient, provider, and health care system characteristics associated with overuse in bronchiolitis.","volume":"148","author":"Wolf","year":"2021","journal-title":"Pediatrics"},{"key":"R20-20260313","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1542\/peds.2013-1991","article-title":"Impact of a bronchiolitis guideline on ED resource use and cost: A segmented time-series analysis.","volume":"133","author":"Akenroye","year":"2014","journal-title":"Pediatrics"},{"key":"R21-20260313","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2013-2005","article-title":"Bronchiolitis management before and after the AAP guidelines.","volume":"133","author":"Parikh","year":"2014","journal-title":"Pediatrics"},{"key":"R22-20260313","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2014.18399","article-title":"Protocolized sedation vs usual care in pediatric patients mechanically ventilated for acute respiratory failure.","volume":"313","author":"Curley","year":"2015","journal-title":"JAMA"},{"key":"R23-20260313","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD.","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R24-20260313","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/PCC.0000000000000306","article-title":"Risk factors associated with iatrogenic opioid and benzodiazepine withdrawal in critically ill pediatric patients.","volume":"16","author":"Best","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R25-20260313","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2014.18399","article-title":"Protocolized sedation vs usual care in pediatric patients mechanically ventilated for acute respiratory failure: A randomized clinical trial.","volume":"313","author":"Curley","year":"2015","journal-title":"JAMA"},{"key":"R26-20260313","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/00003246-199907000-00008","article-title":"Motor Activity Assessment Scale.","volume":"27","author":"Devlin","year":"1999","journal-title":"Crit Care Med"},{"key":"R27-20260313","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1523\/JNEUROSCI.1982-21.2021","article-title":"Contribution of G-protein \u03b1-subunits to analgesia, hyperalgesia, and hyperalgesic priming induced by subanalgesic and analgesic doses of fentanyl and morphine.","volume":"42","author":"Araldi","year":"2022","journal-title":"J Neurosci"},{"key":"R28-20260313","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/PCC.0000000000001719","article-title":"Implementation of a risk-stratified opioid and benzodiazepine weaning protocol in a pediatric cardiac ICU.","volume":"19","author":"Amirnovin","year":"2018","journal-title":"Pediatr Crit Care Med"},{"key":"R29-20260313","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/jpm.1999.2.209","article-title":"Opioid equianalgesic calculations.","volume":"2","author":"Gordon","year":"1999","journal-title":"J Palliat Med"},{"key":"R30-20260313","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/PCC.0000000000002869","article-title":"An antiracism approach to conducting, reporting, and evaluating pediatric critical care research.","volume":"23","author":"Zurca","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"R31-20260313","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2431-14-199","article-title":"Pediatric complex chronic conditions classification system version 2: Updated for ICD-10 and complex medical technology dependence and transplantation.","volume":"14","author":"Feudtner","year":"2014","journal-title":"BMC Pediatr"},{"key":"R33-20260313","doi-asserted-by":"crossref","first-page":"e1208","DOI":"10.1542\/peds.2009-0489","article-title":"Tolerance and withdrawal from prolonged opioid use in critically ill children.","volume":"125","author":"Anand","year":"2010","journal-title":"Pediatrics"},{"key":"R35-20260313","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tins.2011.11.001","article-title":"Trisomy 21 and early brain development.","volume":"35","author":"Haydar","year":"2012","journal-title":"Trends Neurosci"},{"key":"R36-20260313","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s12887-024-04971-0","article-title":"Opioid and benzodiazepine requirements in critically ill post-surgical children with Down syndrome: A systematic review and meta-analysis.","volume":"24","author":"Alsulami","year":"2024","journal-title":"BMC Pediatr"},{"key":"R37-20260313","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/S0140-6736(00)03259-1","article-title":"Pain expression and stimulus localisation in individuals with Down\u2019s syndrome.","volume":"356","author":"Hennequin","year":"2000","journal-title":"Lancet"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:00:14Z","timestamp":1773417614000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001391","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}